CL2019001380A1 - Unidad de tejido nervioso y utilización de una unidad de este tipo para la implantación en el sistema nervioso de un mamífero. - Google Patents
Unidad de tejido nervioso y utilización de una unidad de este tipo para la implantación en el sistema nervioso de un mamífero.Info
- Publication number
- CL2019001380A1 CL2019001380A1 CL2019001380A CL2019001380A CL2019001380A1 CL 2019001380 A1 CL2019001380 A1 CL 2019001380A1 CL 2019001380 A CL2019001380 A CL 2019001380A CL 2019001380 A CL2019001380 A CL 2019001380A CL 2019001380 A1 CL2019001380 A1 CL 2019001380A1
- Authority
- CL
- Chile
- Prior art keywords
- unit
- nervous tissue
- nervous
- implantation
- mammal
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 2
- 238000002513 implantation Methods 0.000 title abstract 2
- 210000000653 nervous system Anatomy 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 abstract 2
- 239000000017 hydrogel Substances 0.000 abstract 2
- 210000002569 neuron Anatomy 0.000 abstract 2
- 230000001413 cellular effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3675—Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0012—Cell encapsulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/42—Notch; Delta; Jagged; Serrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
Abstract
LA INVENCIÓN SE REFIERE A UNA UNIDAD DE TEJIDO NERVIOSO PARA SU UTILIZACIÓN PARA UNA IMPLANTACIÓN EN EL SISTEMA NERVIOSO DE UN MAMÍFERO HUMANO O NO HUMANO, EN LA QUE DICHA UNIDAD DE TEJIDO NERVIOSO CONTIENE CÉLULAS NEURONALES POSTMITÓTICAS DIFERENCIADAS, EN UNA MATRIZ EXTRACELULAR, DICHA UNIDAD OBTENIÉNDOSE A PARTIR DE UN MICROCOMPARTIMENTO CELULAR COMPRENDIENDO UNA CÁPSULA DE HIDROGEL QUE RODEA DICHA UNIDAD DE TEJIDO NERVIOSO Y DICHA CÁPSULA DE HIDROGEL ESTANDO AL MENOS PARCIALMENTE ELIMINADA ANTES DE LA UTILIZACIÓN DE LA UNIDAD DE TEJIDO NERVIOSO. LA INVENCIÓN SE REFIERE IGUALMENTE A UN PROCEDIMIENTO DE PREPARACIÓN DE UNA UNIDAD DE TEJIDO NERVIOSO DE ESTE TIPO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1661378A FR3058892B1 (fr) | 2016-11-23 | 2016-11-23 | Unite de tissu neural et utilisation d'une telle unite pour l'implantation dans le systeme nerveux d'un mammifere |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019001380A1 true CL2019001380A1 (es) | 2019-12-27 |
Family
ID=58992917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019001380A CL2019001380A1 (es) | 2016-11-23 | 2019-05-22 | Unidad de tejido nervioso y utilización de una unidad de este tipo para la implantación en el sistema nervioso de un mamífero. |
Country Status (20)
Country | Link |
---|---|
US (2) | US20200063099A1 (es) |
EP (2) | EP3544619B1 (es) |
JP (2) | JP7209300B2 (es) |
KR (2) | KR102636762B1 (es) |
CN (2) | CN110730667B (es) |
AU (2) | AU2017365847B2 (es) |
BR (1) | BR112019010514A2 (es) |
CA (1) | CA3042113C (es) |
CL (1) | CL2019001380A1 (es) |
CY (1) | CY1124892T1 (es) |
DK (2) | DK3544619T3 (es) |
ES (1) | ES2898837T3 (es) |
FI (1) | FI3903795T3 (es) |
FR (1) | FR3058892B1 (es) |
IL (2) | IL295963A (es) |
LT (2) | LT3544619T (es) |
MX (1) | MX2019006048A (es) |
PL (1) | PL3544619T3 (es) |
PT (2) | PT3544619T (es) |
WO (1) | WO2018096278A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3059009B1 (fr) | 2016-11-23 | 2018-12-07 | Universite de Bordeaux | Microcompartiment cellulaire et procedes de preparation |
KR20210132638A (ko) * | 2018-10-26 | 2021-11-04 | 테사라 테라퓨틱스 피티와이 리미티드 | 신경계 세포 요법 |
FR3099882A1 (fr) * | 2019-08-12 | 2021-02-19 | Treefrog Therapeutics | Unité tridimensionnelle creuse de tissu rétinien et utilisation dans le traitement des rétinopathies |
CN114729323A (zh) | 2019-11-22 | 2022-07-08 | 诺和诺德股份有限公司 | 旋转聚集的神经微球及其应用 |
JP2024509088A (ja) * | 2021-02-24 | 2024-02-29 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 脳への聴覚入力を回復または増強するための事前形成された神経組織 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250294B2 (en) * | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
CN1367245A (zh) * | 2001-08-10 | 2002-09-04 | 谢佐平 | 一种诱导神经干细胞转化为多巴胺能神经元的技术 |
ZA200401646B (en) * | 2003-03-12 | 2004-06-07 | Reliance Life Sciences Pvt Ltd | Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells. |
EP2913393B8 (en) * | 2004-11-17 | 2020-02-26 | Seneca Biopharma, Inc. | Transplantation of human neural cells for treatment of neurodegenerative conditions |
WO2011091048A1 (en) * | 2010-01-19 | 2011-07-28 | The Board Of Trustees Of The Leland Stanford Junior University | Direct conversion of cells to cells of other lineages |
KR20190042747A (ko) * | 2011-06-02 | 2019-04-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 생체외 조직 배양 시스템을 위한 방법 및 용도 |
PT2773748T (pt) * | 2011-11-04 | 2020-03-26 | Memorial Sloan Kettering Cancer Center | Neurónios dopaminérgicos (da) do mesencéfalo para enxerto |
EP2743345A1 (en) * | 2012-12-13 | 2014-06-18 | IMBA-Institut für Molekulare Biotechnologie GmbH | Three dimensional heterogeneously differentiated tissue culture |
JP2015047140A (ja) * | 2013-09-03 | 2015-03-16 | 国立大学法人京都大学 | 移植後の生着能を有する神経細胞と固体3次元マトリックスとの複合体 |
CN106103702B (zh) * | 2013-11-22 | 2020-03-24 | 国立研究开发法人理化学研究所 | 制备端脑或其前体组织的方法 |
WO2016140716A1 (en) * | 2015-03-02 | 2016-09-09 | The Trustees Of Columbia University In The City Of New York | Injectable microtissue systems, devices, and methods |
LU92845B1 (en) * | 2015-10-08 | 2017-05-02 | Univ Du Luxembourg Campus Belval | Means and methods for generating midbrain organoids |
WO2017083705A1 (en) * | 2015-11-13 | 2017-05-18 | The Johns Hopkins University | Cell culture system and method of use thereof |
-
2016
- 2016-11-23 FR FR1661378A patent/FR3058892B1/fr active Active
-
2017
- 2017-11-23 KR KR1020227007527A patent/KR102636762B1/ko active IP Right Grant
- 2017-11-23 IL IL295963A patent/IL295963A/en unknown
- 2017-11-23 PT PT178177796T patent/PT3544619T/pt unknown
- 2017-11-23 CN CN201780071968.5A patent/CN110730667B/zh active Active
- 2017-11-23 CA CA3042113A patent/CA3042113C/fr active Active
- 2017-11-23 AU AU2017365847A patent/AU2017365847B2/en active Active
- 2017-11-23 PL PL17817779T patent/PL3544619T3/pl unknown
- 2017-11-23 MX MX2019006048A patent/MX2019006048A/es unknown
- 2017-11-23 JP JP2019547790A patent/JP7209300B2/ja active Active
- 2017-11-23 US US16/462,965 patent/US20200063099A1/en active Pending
- 2017-11-23 KR KR1020197016905A patent/KR102372929B1/ko active IP Right Grant
- 2017-11-23 DK DK17817779.6T patent/DK3544619T3/da active
- 2017-11-23 ES ES17817779T patent/ES2898837T3/es active Active
- 2017-11-23 CN CN202311178608.9A patent/CN117286107A/zh active Pending
- 2017-11-23 LT LTEPPCT/FR2017/053226T patent/LT3544619T/lt unknown
- 2017-11-23 DK DK21180715.1T patent/DK3903795T3/da active
- 2017-11-23 PT PT211807151T patent/PT3903795T/pt unknown
- 2017-11-23 BR BR112019010514A patent/BR112019010514A2/pt unknown
- 2017-11-23 EP EP17817779.6A patent/EP3544619B1/fr active Active
- 2017-11-23 EP EP21180715.1A patent/EP3903795B1/fr active Active
- 2017-11-23 LT LTEP21180715.1T patent/LT3903795T/lt unknown
- 2017-11-23 FI FIEP21180715.1T patent/FI3903795T3/en active
- 2017-11-23 WO PCT/FR2017/053226 patent/WO2018096278A1/fr unknown
-
2019
- 2019-05-21 IL IL266773A patent/IL266773B2/en unknown
- 2019-05-22 CL CL2019001380A patent/CL2019001380A1/es unknown
-
2021
- 2021-12-08 CY CY20211101078T patent/CY1124892T1/el unknown
-
2022
- 2022-04-29 AU AU2022202869A patent/AU2022202869A1/en active Pending
- 2022-12-26 JP JP2022208482A patent/JP2023052084A/ja active Pending
-
2023
- 2023-03-22 US US18/124,921 patent/US20230257699A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019001380A1 (es) | Unidad de tejido nervioso y utilización de una unidad de este tipo para la implantación en el sistema nervioso de un mamífero. | |
CL2017002066A1 (es) | Proteasas de cisteína | |
EA201692241A1 (ru) | Контейнер, индикаторное устройство и небулайзер | |
CR20150021A (es) | Método para convertir insectos o gusanos en flujos de nutrientes y composiciones obtenidas de esta manera | |
UY35427A (es) | Compuestos y sus usos en la modulación de la hemoglobina | |
BR112017005381A2 (pt) | composições que compreendem células recombinantes de bacillus e um inseticida. | |
HN2012001223A (es) | Antagonistas de pcsk 9 | |
UY35425A (es) | Compuestos y sus usos en la modulación de la hemoglobina | |
UY35426A (es) | Compuestos y sus usos en la modulación de la hemoglobina | |
EA201792307A1 (ru) | Способы репарации и регенерации тканей | |
CL2019002251A1 (es) | Anticuerpos contra triptasa, composiciones de estos y usos de estos. | |
CY1122615T1 (el) | Θεραπεια με βλαστοκυτταρα σε παθολογιες τουενδομητριου | |
BR112017005504A2 (pt) | composições que compreendem células recombinantes de bacillus e um inseticida. | |
CL2017002020A1 (es) | Dispositivo de apriete y procedimiento para el montaje de un módulo solar | |
DOP2017000032A (es) | Sistema y metodo de acuicultura | |
CL2018001775A1 (es) | Unidades de administración de agroquímicos de liberación controlada, su fabricación y uso | |
AR099500A1 (es) | Composición para el desmucilaginado enzimático de aceite | |
BR112018015923A2 (pt) | instalação para preparação de uma solução aquosa, e, uso de uma instalação | |
NZ721835A (en) | An osseointegrable device | |
BR112016028910A2 (pt) | sistema e método para ancoragem de válvula cardíaca | |
GT201400151A (es) | Cucurbitáceas androicas, procedimientos de obtención y utilizaciones de estas cucurbitáceas | |
ES2514140B1 (es) | Uso del inhibidor de sulfatasas esteroideas STX64 para el tratamiento del envejecimiento | |
CO2017013361A2 (es) | Angiogénesis usando células madre placentarias estimuladas | |
BR112015024877A2 (pt) | vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose | |
CL2016002380A1 (es) | Dispositivo de limpieza para instrumentos médicos y métodos relacionados de utilización. |